Does LATANOPROST Cause Mobility decreased? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Mobility decreased have been filed in association with LATANOPROST (IYUZEH). This represents 0.1% of all adverse event reports for LATANOPROST.
18
Reports of Mobility decreased with LATANOPROST
0.1%
of all LATANOPROST reports
0
Deaths
3
Hospitalizations
How Dangerous Is Mobility decreased From LATANOPROST?
Of the 18 reports, 3 (16.7%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LATANOPROST. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does LATANOPROST Cause?
Treatment failure (5,781)
Drug ineffective (1,338)
Eye irritation (1,165)
Eye pain (668)
Hypersensitivity (668)
Ocular hyperaemia (587)
Intraocular pressure increased (579)
Vision blurred (564)
Cataract (546)
Visual impairment (382)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which LATANOPROST Alternatives Have Lower Mobility decreased Risk?
LATANOPROST vs LATANOPROSTENE BUNOD
LATANOPROST vs LATANOPROST\NETARSUDIL
LATANOPROST vs LATANOPROST\TIMOLOL
LATANOPROST vs LATISSE
LATANOPROST vs LATUDA